Form 4 for ANIP ANI PHARMACEUTICALS INC
Accepted 2026-06-09 18:33:44 ET · period of report 2026-06-05 · accession 0001674236-26-000013 · SEC index · Original document
Summary rows
Aggregated the way they appear in lists: one row per insider, transaction code and security table.
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| DT | 2026-06-09 18:33 | 2026-06-05 | ANIP | CAREY STEPHEN P. | SVP, CFO | M - OptEx | $49.51 | +3,312 | 183.7K | +2% | +$164.0K |
| DT | 2026-06-09 18:33 | 2026-06-05 | ANIP | CAREY STEPHEN P. | SVP, CFO | S - Sale+OE | $80.00 | -3,312 | 180.4K | -2% | -$265.0K |
| DT | 2026-06-09 18:33 | 2026-06-05 | ANIP | CAREY STEPHEN P. | SVP, CFO | M - OptEx | $49.51 | -3,312 | 6,626 | -33% | -$164.0K |
Purchase Sale Sale after option exercise All abbreviations
Every reported transaction
| # | Table | Security | Date | Code | A/D | Shares | Price | Owned after | Own | Exercise / expiry | Underlying | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Common | Common Stock | 2026-06-05 | M | A | 3,312 | $49.51 | 183,705 | D | — | — | (F1) The stock option exercise and sale reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on March 6, 2026. |
| 2 | Common | Common Stock | 2026-06-05 | S | D | 3,312 | $80.00 | 180,393 | D | — | — | (F1) The stock option exercise and sale reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on March 6, 2026. |
| 3 | Derivative | Stock Option (right to buy) | 2026-06-05 | M | D | 3,312 | $49.51 | 6,626 | D | $49.51 · — to 2027-03-30 | 3,312 Common Stock | (F1) The stock option exercise and sale reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on March 6, 2026. (F2) 25% of the total options vested on each of March 31, 2018, March 31, 2019, March 31, 2020, and March 31, 2021. |